These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26187015)

  • 1. Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines.
    Akinboye ES; Bamji ZD; Kwabi-Addo B; Ejeh D; Copeland RL; Denmeade SR; Bakare O
    Bioorg Med Chem; 2015 Sep; 23(17):5839-45. PubMed ID: 26187015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic Effects of Novel Dithiocarbamate Analogs of Emetine in Prostate Cancer Cell Lines.
    Bamji ZD; Washington KN; Akinboye E; Bakare O; Kanaan YM; Copeland RL
    Anticancer Res; 2015 Sep; 35(9):4723-32. PubMed ID: 26254362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer.
    Akinboye ES; Rosen MD; Denmeade SR; Kwabi-Addo B; Bakare O
    J Med Chem; 2012 Sep; 55(17):7450-9. PubMed ID: 22867001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
    Akinboye ES; Rosen MD; Bakare O; Denmeade SR
    Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
    Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
    Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
    Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
    Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
    Ouellette V; Côté MF; Gaudreault RC; Tajmir-Riahi HA; Bérubé G
    Eur J Med Chem; 2019 Oct; 179():660-666. PubMed ID: 31279298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives.
    Birgül K; Yıldırım Y; Karasulu HY; Karasulu E; Uba AI; Yelekçi K; Bekçi H; Cumaoğlu A; Kabasakal L; Yılmaz Ö; Küçükgüzel ŞG
    Eur J Med Chem; 2020 Dec; 208():112841. PubMed ID: 32998089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.
    Brandy Y; Ononiwu I; Adedeji D; Williams V; Mouamba C; Kanaan Y; Copeland RL; Wright DA; Butcher RJ; Denmeade SR; Bakare O
    Invest New Drugs; 2012 Aug; 30(4):1709-14. PubMed ID: 21243402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
    Chen H; Liang X; Xu F; Xu B; He X; Huang B; Yuan M
    Molecules; 2014 Aug; 19(8):12048-64. PubMed ID: 25120056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
    Schmitt J; Noble A; Otsuka M; Berry P; Maitland NJ; Rumsby MG
    Br J Cancer; 2014 Oct; 111(8):1646-56. PubMed ID: 25137020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines.
    Szyszka M; Tyczewska M; Milecka P; Jopek K; Celichowski P; Malendowicz LK; Rucinski M
    Oncol Rep; 2018 Jan; 39(1):182-192. PubMed ID: 29115533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
    Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
    Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Induction of DNA Damage and Cell Cycle Arrest Mediated by Chromone-Triazole Dyads Derivatives: Effects on Breast and Prostate Cancer Cells.
    Saher L; Monteiro FL; Rocha DHA; Albuquerque HMT; Silva AMS; Helguero LA
    Chem Biodivers; 2023 Jul; 20(7):e202300251. PubMed ID: 37387248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel C
    Vesper AR; Lacroix J; C-Gaudreault R; Tajmir-Rihai HA; Bérubé G
    Steroids; 2016 Nov; 115():98-104. PubMed ID: 27553724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of deshydroxy bicalutamide derivatives as androgen receptor antagonists.
    Kandil S; Lee KY; Davies L; Rizzo SA; Dart DA; Westwell AD
    Eur J Med Chem; 2019 Apr; 167():49-60. PubMed ID: 30743097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer.
    Yano S; Matsuyama H; Hirata H; Inoue R; Matsumoto H; Ohmi C; Miura K; Shirai M; Iizuka N; Naito K
    Oncol Rep; 2006 Jun; 15(6):1453-60. PubMed ID: 16685379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.